Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.96
RMD's Cash to Debt is ranked higher than
74% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. RMD: 1.96 )
RMD' s 10-Year Cash to Debt Range
Min: 0.33   Max: No Debt
Current: 1.96

Equity to Asset 0.68
RMD's Equity to Asset is ranked higher than
79% of the 301 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. RMD: 0.68 )
RMD' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.86
Current: 0.68

0.34
0.86
Interest Coverage 66.09
RMD's Interest Coverage is ranked higher than
73% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.80 vs. RMD: 66.09 )
RMD' s 10-Year Interest Coverage Range
Min: 26.38   Max: 9999.99
Current: 66.09

26.38
9999.99
F-Score: 6
Z-Score: 11.44
M-Score: -2.51
WACC vs ROIC
5.83%
28.73%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 25.18
RMD's Operating margin (%) is ranked higher than
96% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.92 vs. RMD: 25.18 )
RMD' s 10-Year Operating margin (%) Range
Min: -25.07   Max: 28.66
Current: 25.18

-25.07
28.66
Net-margin (%) 21.79
RMD's Net-margin (%) is ranked higher than
96% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. RMD: 21.79 )
RMD' s 10-Year Net-margin (%) Range
Min: 7.5   Max: 22.2
Current: 21.79

7.5
22.2
ROE (%) 21.14
RMD's ROE (%) is ranked higher than
94% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. RMD: 21.14 )
RMD' s 10-Year ROE (%) Range
Min: 7.94   Max: 26.85
Current: 21.14

7.94
26.85
ROA (%) 15.04
RMD's ROA (%) is ranked higher than
95% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. RMD: 15.04 )
RMD' s 10-Year ROA (%) Range
Min: 5.76   Max: 21.63
Current: 15.04

5.76
21.63
ROC (Joel Greenblatt) (%) 50.49
RMD's ROC (Joel Greenblatt) (%) is ranked higher than
91% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.59 vs. RMD: 50.49 )
RMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -44.93   Max: 68.56
Current: 50.49

-44.93
68.56
Revenue Growth (3Y)(%) 10.80
RMD's Revenue Growth (3Y)(%) is ranked higher than
88% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. RMD: 10.80 )
RMD' s 10-Year Revenue Growth (3Y)(%) Range
Min: 10.8   Max: 33.9
Current: 10.8

10.8
33.9
EBITDA Growth (3Y)(%) 14.00
RMD's EBITDA Growth (3Y)(%) is ranked higher than
81% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. RMD: 14.00 )
RMD' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 5.9   Max: 81.7
Current: 14

5.9
81.7
EPS Growth (3Y)(%) 18.40
RMD's EPS Growth (3Y)(%) is ranked higher than
85% of the 227 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.20 vs. RMD: 18.40 )
RMD' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 65.8
Current: 18.4

0
65.8
» RMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

RMD Guru Trades in Q1 2014

Joel Greenblatt 530,016 sh (+125.65%)
Jeremy Grantham 170,814 sh (+97.54%)
Chase Coleman 1,000,000 sh (unchged)
Chuck Royce 46,800 sh (unchged)
Jean-Marie Eveillard 22,000 sh (unchged)
John Hussman Sold Out
Steven Cohen Sold Out
Paul Tudor Jones 10,683 sh (-37.23%)
Jim Simons 14,800 sh (-97.61%)
» More
Q2 2014

RMD Guru Trades in Q2 2014

Chuck Royce 48,333 sh (+3.28%)
Jeremy Grantham 175,314 sh (+2.63%)
Chase Coleman 1,000,000 sh (unchged)
Paul Tudor Jones Sold Out
Jean-Marie Eveillard Sold Out
Jim Simons Sold Out
Joel Greenblatt 18,321 sh (-96.54%)
» More
Q3 2014

RMD Guru Trades in Q3 2014

Chase Coleman 1,000,000 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 47,368 sh (-2.00%)
Jeremy Grantham 134,714 sh (-23.16%)
» More
Q4 2014

RMD Guru Trades in Q4 2014

Steven Cohen 215,700 sh (New)
Jim Simons 452,900 sh (New)
Paul Tudor Jones 5,100 sh (New)
John Hussman 3,500 sh (New)
Chuck Royce Sold Out
Chase Coleman Sold Out
Jeremy Grantham 110,903 sh (-17.68%)
» More
» Details

Insider Trades

Latest Guru Trades with RMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.60
RMD's P/E(ttm) is ranked higher than
82% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.70 vs. RMD: 29.60 )
RMD' s 10-Year P/E(ttm) Range
Min: 16.9   Max: 66.2
Current: 29.6

16.9
66.2
Forward P/E 56.50
RMD's Forward P/E is ranked higher than
99% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 163.93 vs. RMD: 56.50 )
N/A
PE(NRI) 29.60
RMD's PE(NRI) is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.30 vs. RMD: 29.60 )
RMD' s 10-Year PE(NRI) Range
Min: 16.93   Max: 66.36
Current: 29.6

16.93
66.36
P/B 6.40
RMD's P/B is ranked lower than
52% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.96 vs. RMD: 6.40 )
RMD' s 10-Year P/B Range
Min: 2.29   Max: 6.57
Current: 6.4

2.29
6.57
P/S 6.45
RMD's P/S is ranked lower than
65% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.29 vs. RMD: 6.45 )
RMD' s 10-Year P/S Range
Min: 2.78   Max: 6.93
Current: 6.45

2.78
6.93
PFCF 32.41
RMD's PFCF is ranked higher than
76% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 108.70 vs. RMD: 32.41 )
RMD' s 10-Year PFCF Range
Min: 13.43   Max: 284.56
Current: 32.41

13.43
284.56
POCF 25.32
RMD's POCF is ranked higher than
76% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.76 vs. RMD: 25.32 )
RMD' s 10-Year POCF Range
Min: 10.7   Max: 51.06
Current: 25.32

10.7
51.06
EV-to-EBIT 24.12
RMD's EV-to-EBIT is ranked higher than
82% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.92 vs. RMD: 24.12 )
RMD' s 10-Year EV-to-EBIT Range
Min: 12.4   Max: 48.5
Current: 24.12

12.4
48.5
PEG 1.67
RMD's PEG is ranked higher than
95% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 1.67 )
RMD' s 10-Year PEG Range
Min: 0.64   Max: 5.64
Current: 1.67

0.64
5.64
Shiller P/E 39.78
RMD's Shiller P/E is ranked higher than
80% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 39.78 )
RMD' s 10-Year Shiller P/E Range
Min: 24.48   Max: 67.17
Current: 39.78

24.48
67.17
Current Ratio 6.00
RMD's Current Ratio is ranked higher than
93% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. RMD: 6.00 )
RMD' s 10-Year Current Ratio Range
Min: 0.87   Max: 6.44
Current: 6

0.87
6.44
Quick Ratio 5.16
RMD's Quick Ratio is ranked higher than
93% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. RMD: 5.16 )
RMD' s 10-Year Quick Ratio Range
Min: 0.61   Max: 5.71
Current: 5.16

0.61
5.71
Days Inventory 111.87
RMD's Days Inventory is ranked higher than
79% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 135.02 vs. RMD: 111.87 )
RMD' s 10-Year Days Inventory Range
Min: 100.51   Max: 183.38
Current: 111.87

100.51
183.38
Days Sales Outstanding 76.88
RMD's Days Sales Outstanding is ranked higher than
68% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.75 vs. RMD: 76.88 )
RMD' s 10-Year Days Sales Outstanding Range
Min: 57.87   Max: 89.17
Current: 76.88

57.87
89.17

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.49
RMD's Dividend Yield is ranked higher than
63% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.22 vs. RMD: 1.49 )
RMD' s 10-Year Dividend Yield Range
Min: 0.41   Max: 2.2
Current: 1.49

0.41
2.2
Dividend Payout 0.43
RMD's Dividend Payout is ranked higher than
85% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 0.43 )
RMD' s 10-Year Dividend Payout Range
Min: 0.29   Max: 0.48
Current: 0.43

0.29
0.48
Yield on cost (5-Year) 1.50
RMD's Yield on cost (5-Year) is ranked higher than
53% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.58 vs. RMD: 1.50 )
RMD' s 10-Year Yield on cost (5-Year) Range
Min: 0.41   Max: 2.2
Current: 1.5

0.41
2.2
Share Buyback Rate 2.80
RMD's Share Buyback Rate is ranked higher than
95% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -1.70 vs. RMD: 2.80 )
RMD' s 10-Year Share Buyback Rate Range
Min: 2.8   Max: -19.8
Current: 2.8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 71.49
RMD's Price/Net Cash is ranked higher than
85% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 71.49 )
RMD' s 10-Year Price/Net Cash Range
Min: 11.81   Max: 301.29
Current: 71.49

11.81
301.29
Price/Net Current Asset Value 12.40
RMD's Price/Net Current Asset Value is ranked higher than
81% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 12.40 )
RMD' s 10-Year Price/Net Current Asset Value Range
Min: 1.63   Max: 1340
Current: 12.4

1.63
1340
Price/Tangible Book 8.02
RMD's Price/Tangible Book is ranked higher than
62% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.60 vs. RMD: 8.02 )
RMD' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 35.03
Current: 8.02

1.5
35.03
Price/DCF (Projected) 2.07
RMD's Price/DCF (Projected) is ranked higher than
79% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. RMD: 2.07 )
RMD' s 10-Year Price/DCF (Projected) Range
Min: 1.34   Max: 22.58
Current: 2.07

1.34
22.58
Price/Median PS Value 1.42
RMD's Price/Median PS Value is ranked higher than
67% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. RMD: 1.42 )
RMD' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 2.57
Current: 1.42

0.49
2.57
Price/Peter Lynch Fair Value 1.83
RMD's Price/Peter Lynch Fair Value is ranked higher than
94% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 1.83 )
RMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.7   Max: 6.74
Current: 1.83

0.7
6.74
Price/Graham Number 3.21
RMD's Price/Graham Number is ranked higher than
82% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. RMD: 3.21 )
RMD' s 10-Year Price/Graham Number Range
Min: 1.47   Max: 14.66
Current: 3.21

1.47
14.66
Earnings Yield (Greenblatt) 4.10
RMD's Earnings Yield (Greenblatt) is ranked higher than
77% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. RMD: 4.10 )
RMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 8.1
Current: 4.1

2.1
8.1
Forward Rate of Return (Yacktman) 18.71
RMD's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.67 vs. RMD: 18.71 )
RMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 12.2   Max: 31.2
Current: 18.71

12.2
31.2

Analyst Estimate

Jun15 Jun16 Jun17
Revenue(Mil) 1,641 1,762 1,633
EPS($) 1.16 1.27 0.26
EPS without NRI($) 1.16 1.27 0.26

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RMD.Australia, RME.Germany, RMEA.Germany, RSMDF.USA,
ResMed Inc a Delaware corporation was formed in March 1994. The Company is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, or SDB. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. SDB includes obstructive sleep apnea, or OSA, and other respiratory disorders that occur during sleep. The Company markets its products in more than 100 countries to sleep clinics, home healthcare dealers and third-party payors. It also market the products directly to sleep clinics. The Company's portfolio of products includes airflow generators, diagnostic products, mask systems, headgear and other accessories. The Company produces CPAP, VPAP and AutoSet systems for the titration and treatment of SDB. The flow generator systems deliver positive airway pressure through a patient interface, either a small nasal mask, nasal pillows system, or full-face mask. The Company's competitors include Philips BV; DeVilbiss Healthcare; Fisher & Paykel Healthcare Corporation Limited; Apex Medical Corporation; BMC Medical Co. Ltd.; and regional manufacturers. The Company's products are subject to extensive regulation particularly as to safety, efficacy and adherence to FDA Quality System Regulation, and related manufacturing standards. Medical device products are subject to rigorous FDA and other governmental agency regulations in the United States and similar regulations of foreign agencies abroad.
» More Articles for RMD

Headlines

Articles On GuruFocus.com
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
These 7 Growth Stocks Have Potential To Make You Rich Sep 14 2014 
Buy ResMed and Sleep Tight (Like Jim Simons) Feb 02 2014 
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
Meeting the Herd Mar 25 2013 
The Best Yielding Ex-Dividend Stocks on February 14, 2013 Feb 13 2013 
Weekly CEO Sells Highlight: ResMed Inc., Chuy’s Holdings Inc., Electronics for Imaging Inc., Coher Feb 04 2013 
ResMed - Growing Business with Consistent Cash Flow Generation at Lowest 10-Year Valuation Jan 24 2012 
predictable hussma Sep 30 2011 
Weekly CFO Sells Highlight: RMD, CATM, HXL, BCR, AMRC Jul 24 2011 

More From Other Websites
ResMed To Announce Third Quarter 2015 Results Apr 02 2015
ResMed To Announce Third Quarter 2015 Results Apr 02 2015
ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at... Mar 12 2015
ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at... Mar 12 2015
ResMed Makes It Big on Women's Day, Unveils SDB Device - Analyst Blog Mar 10 2015
ResMed Launches AirSense 10 AutoSet for Her: A Complete Integrated Sleep Solution for Europe's 1 in... Mar 06 2015
ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog Feb 24 2015
Australian shares slip as Greek worries weigh Feb 16 2015
ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action Feb 12 2015
ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action Feb 12 2015
ResMed Targets Expansion in HME Market, Acquires Jaysec - Analyst Blog Feb 11 2015
ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment... Feb 10 2015
RESMED INC Financials Feb 05 2015
Easy-to-Use AirView™ Patient Management System by ResMed Now Integrates Directly with Brightree Feb 02 2015
Easy-to-Use AirView™ Patient Management System by ResMed Now Integrates Directly with Brightree Feb 02 2015
10-Q for ResMed, Inc. Feb 01 2015
RESMED INC Files SEC form 10-Q, Quarterly Report Jan 30 2015
ResMed (RMD) Beats Q2 Earnings & Revenues, Margin Falls - Analyst Blog Jan 26 2015
ResMed Stock Hits High As Growth Reignites Jan 23 2015
ResMed (RMD) Stock Continues to Rise Today on Strong Quarterly Results Jan 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK